The preclinical discovery and development of gepirone hydrochloride extended-release tablets: the first oral selective 5-HT1A receptor agonist for the treatment of major depressive disorder
用户6hlF9RUjCxw4
1个月前
64
10
已完结
1. 系统已在2025-09-09 17:59:24对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1080/17460441.2025.2552144
文献链接: https://www.tandfonline.com/doi/full/10.1080/17460441.2025.2552144
其他信息:
出版社: Informa UK Limited
作者: George Konstantakopoulos; Dionysios Argyropoulos; Antonis Tsionis
